GAY ROBERT C Insider Trades

Insider Trading History

Track insider trading activity for GAY ROBERT C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Angel Studios
Angel Studios ANGX
Director
Holding Value $21.7k 5,297 shares
Last Trade
May 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15k 5,296 shares
$2.83
$4.10
Angel Studios
Angel Studios ANGX
Director
Holding Value $21.7k 5,296 shares
Last Trade
May 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15k 5,296 shares
$2.83
$4.10
Angel Studios
Angel Studios ANGX
Director
Holding Value $43.5k 10,593 shares
Last Trade
Oct 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.10
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $9.64M 636,346 shares
Last Trade
Apr 03, 2012 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.72M 142,857 shares
$54.06
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $7.47M 493,489 shares
Last Trade
Apr 03, 2012 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$9.48M 175,316 shares
$54.06
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $4.82M 318,173 shares
Last Trade
Apr 03, 2012 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.72M 142,857 shares
$54.06
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $2.66M 175,316 shares
Last Trade
Apr 03, 2012 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$9.48M 175,316 shares
$54.06
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2012 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$6.14M 113,586 shares
$54.06
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2012 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.72M 142,857 shares
$54.06
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2012 Sale
No data
No data
$15.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up